Full-Time

Software Engineering Track – Investment Services & Technology Early Career Program

Class of 2024, Boston

Posted on 9/7/2023

Wellington Management

Wellington Management

1,001-5,000 employees

Global asset management for institutional clients

No salary listed

Company Historically Provides H1B Sponsorship

Cambridge, MA, USA

Category
Software Engineering

Get referred to Wellington Management

See people who can refer or advise you

Requirements
  • Undergraduates graduating with a Bachelor's degree between Fall 2023 - Summer 2024
  • Demonstrated interest in technology, and the investment management industry (all backgrounds welcome to apply)
  • Strong academic performance
  • Proven leadership experience and participation in community service and extracurricular activities
  • Internship experience or coursework in software engineering, including design patterns, programming languages, and constructs
  • Superior written and verbal communication skills
  • Well organized, ability to multi-task and detail-oriented
  • Ability to work both individually and collaboratively in a fast-paced environment
  • Ability to learn new concepts and subjects quickly
  • Creative thinker, with the ability to generate independent ideas and thoughts
  • Highly motivated self-starter with a high intellectual curiosity
  • Strong work ethic and professionalism
  • Aptitude for solving complex technical or functional problems
  • Résumé, 1 page length
  • Statement of Interest, 2 pages max page length, that addresses:
  • Why you are interested in Wellington
  • Why you are interested in the Software Engineer Track of the Investment Services & Technology Early Career Program
Responsibilities
  • Build application functionality, leveraging implementation patterns and open-source solutions where appropriate
  • Work closely with business users and analysts to review strategic business requirements and collaborate on design specifications
  • Determine impact to servers, network and storage capacity, and throughput in conjunction with infrastructure delivery teams
Wellington Management

Wellington Management

View

Wellington Management is a global investment management firm that offers equity, fixed income, multi-asset, and alternative investments to both institutional clients (such as pension funds, endowments, foundations, and insurers) and individual investors. It manages assets on behalf of clients, earning fees based on assets under management (AUM) and on investment performance. The firm relies on deep research capabilities and market insights to tailor investment strategies that meet client needs, and it integrates environmental, social, and governance (ESG) factors into its process. What sets Wellington Management apart is its broad suite of investment options combined with a commitment to ESG integration and a client-tailored approach, supported by a culture that emphasizes diversity and inclusion. The company’s goal is to help clients achieve their investment objectives by delivering disciplined, research-driven strategies and sustainable investing over the long term.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

$63.3B

Headquarters

Boston, Massachusetts

Founded

1933

Get referred to Wellington Management

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Insurance mandates support expansion in liability-aware and private-market strategies.[1]
  • Public-private market products can widen distribution across institutional client segments.[10]
  • Defined-contribution and intermediary channels offer adjacent growth beyond pensions and endowments.[7][10]

What critics are saying

  • Passive fee pressure keeps compressing active-management margins across institutional mandates.
  • Relative underperformance in flagship sleeves triggers redemptions and faster AUM decline.
  • Decentralized teams amplify key-person risk and inconsistent performance across the platform.[3]

What makes Wellington Management unique

  • Independent partnership with no chief investment officer shapes team autonomy.[3]
  • Nearly 50 teams cover equities, fixed income, multi-asset, and alternatives.[3]
  • Global private-investing franchise targets insurers, climate technology, and growth-stage companies.[1]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive health coverage

Work-life balance

Financial future

Development

Company News

Synlogic Therapeutics
Jul 29th, 2026
Synlogic and Caldera Therapeutics Announce Merger Agreement and Concurrent Private Placement - Synlogic

The Investor Relations website contains information about Synlogic's business for stockholders, potential investors, and financial analysts.

Radio Intereconomía
Apr 14th, 2026
Wellington launches global market neutral fund to capture alpha in volatile environment

Wellington Management has launched the Wellington Absolute Return Global Equity Fund, a UCITS vehicle employing a global market neutral strategy aimed at generating returns above cash with limited exposure to traditional markets. The fund expands Wellington's liquid alternatives offering. The launch comes amid increased market volatility and reduced stability, positioning the fund to capture alpha in challenging conditions through its market-neutral approach to global equities.

AD HOC NEWS Portal Aktiengesellschaft
Apr 12th, 2026
Wellington buys 5% stake in Renk as $339M in delayed defence contracts weigh on cash flow

Wellington Management has acquired a 5.09% stake in German defence supplier Renk Group, signalling confidence despite the company facing significant operational challenges. The US asset manager built its position through direct share purchases and equity swaps. Renk is currently contending with approximately €300 million in blocked revenue due to delayed deliveries and missing export licenses. Around €200 million in planned sales has been pushed to 2026, whilst €80-100 million in orders for Israeli tank gearbox systems await German export approval. The cash flow pressure is evident, with free cash flow reaching only €67 million last fiscal year, well below the company's 80% conversion target. Shares fell 4.34% to €52.05, extending year-to-date losses to nearly 6%. Despite near-term challenges, Renk maintains a record order backlog of €6.68 billion.

Voyager Therapeutics
Apr 10th, 2026
Voyager Therapeutics Raises $60 Million in Oversubscribed Series B Financing | Voyager Therapeutics Inc.

Gene Therapy Leader to Advance Broad Product Pipeline & AAV Product Engine   Cambridge, Mass., April 13, 2015 – Voyager Therapeutics , a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), today announced the successful

Business Wire
Apr 2nd, 2026
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN) and Korsana Biosciences, Inc. (“Korsana”), a privately-held biotechnology company discovering and d...

INACTIVE